By rray, 13 April, 2023 Once in remission continue antidepressant drug therapeutic dose 6mo to darr relapse risk if high recurrence risk offer maintenance pharmaco tx for 12mo or indefinitely1
By rray, 13 April, 2023 After remission achieved offer cognitive behavioral therapy interpersonal therapy or mindfulness based cognitive therapy during continuation tx phase to darr relapse recurrence risk1 4
By rray, 13 April, 2023 Once in remission continue antidepressant drug therapeutic dose 6mo to darr relapse risk if high recurrence risk offer maintenance pharmaco tx for 12mo or indefinitely1
By rray, 13 April, 2023 After tx initiation change monitor at regular intervals offer psychotherapy to darr relapse risk1
By rray, 11 April, 2023 Create written COPD exac action plan w educational component maintain regular clinician contact
By rray, 11 April, 2023 Consider switching inhaler device or drugs implement escalate nondrug treatments investigate and treat other causes of dyspnea
By rray, 11 April, 2023 If eos 300 cells L Consider ICS LAMA LABA o ICS LAMA LABA combo options budesonide glycopyrrolate formoterol fluticasone furoate umeclidinium vilanterol